Clinical Trials
5 trialsNCT07224776 2026-05-18
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Brigham and Women's Hospital
Phase 1 Not yet recruiting
NCT07561957 2026-05-01
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
St. James's Hospital, Ireland
Phase NA Recruiting
NCT05673824 2026-02-09
Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.
Fudan University
Phase 2 Completed
NCT07358520 2026-01-22
Clinical Study on the Use of Huaier Granules for the Treatment of Proteinuria Related to Bevacizumab and Anlotinib in Lung Cancer Patients
Fudan University
Phase 4 Not yet recruiting
NCT07355361 2026-01-21
N093
Fudan University
Phase 2 Not yet recruiting